Literature DB >> 18024800

Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.

Tom Powles, Justin Stebbing, Silvia Montoto, Mark Nelson, Brian Gazzard, Chloe Orkin, Andy Webb, Mark Bower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18024800     DOI： 10.1182/blood-2007-08-106187

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

Review 1.  HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.

Authors:  Ryan J Sullivan; Liron Pantanowitz; Corey Casper; Justin Stebbing; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

Review 2.  Castleman's disease: systematic analysis of 416 patients from the literature.

Authors:  Nadia Talat; Klaus-Martin Schulte
Journal:  Oncologist       Date:  2011-07-17

3.  Budd-Chiari syndrome, a rare complication of multicentric Castleman disease: A case report.

Authors:  Kui Song; Min Li
Journal:  Oncol Lett       Date:  2015-03-03       Impact factor: 2.967

4.  Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Authors:  Ramya Ramaswami; Kathryn Lurain; Cody J Peer; Anna Serquiña; Victoria Wang; Anaida Widell; Priscila Goncalves; Seth M Steinberg; Vickie Marshall; Jomy George; William D Figg; Denise Whitby; Joseph Ziegelbauer; Thomas S Uldrick; Robert Yarchoan
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

Review 5.  HIV-associated multicentric Castleman disease.

Authors:  Deepa Reddy; Ronald Mitsuyasu
Journal:  Curr Opin Oncol       Date:  2011-09       Impact factor: 3.645

6.  Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.

Authors:  Xinping Zhou; Juying Wei; Yinjun Lou; Gaixiang Xu; Min Yang; Hui Liu; Liping Mao; Hongyan Tong; Jie Jin
Journal:  Front Med       Date:  2017-04-03       Impact factor: 4.592

7.  The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease.

Authors:  J Stebbing; S Ngan; H Ibrahim; P Charles; M Nelson; P Kelleher; K N Naresh; M Bower
Journal:  Clin Exp Immunol       Date:  2008-12       Impact factor: 4.330

8.  Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood.

Authors:  Lan Lin; Jeannette Y Lee; Lawrence D Kaplan; Bruce J Dezube; Ariela Noy; Susan E Krown; Alexandra M Levine; Yanxing Yu; Gary S Hayward; Richard F Ambinder
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

9.  An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection.

Authors:  Yingyun Cai; Edward A Berger
Journal:  Antiviral Res       Date:  2011-03-31       Impact factor: 10.103

10.  HIV-associated multicentric Castleman's disease.

Authors:  Fauzia de Fátima Naime; Felipe Fakhouri; Carlos Saraiva Martins; Wilson José Couto
Journal:  Rare Tumors       Date:  2012-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.